Company Overview of Morphochem, Inc.
Morphochem, Inc. operates as a drug discovery company in the United States. Its drug discovery programs include EDDS technology that is for the identification of drug leads, which modulate the activity of receptors; proteomics program, which identifies ligands for receptors with using EDDS and calcium measurement technologies; and anti-infectives program that is for the discover of novel agents to combat multi-drug resistant bacteria. MorphoChem, Inc., formerly known as Small Molecule Therapeutics, Inc., was founded in 1997 and is based in Monmouth Junction, New Jersey. As of March 20, 2000, MorphoChem, Inc. is a subsidiary of MorphoChem AG.
11 Deerpark Drive
Monmouth Junction, NJ 08852
Founded in 1997
Key Executives for Morphochem, Inc.
Similar Private Companies By Industry
|Covance Laboratories, Inc.||United States|
|Boehringer Ingelheim Corporation||United States|
|Bodyonics Ltd.||United States|
|SAFC, Inc.||United States|
|The UCAN Company||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Morphochem, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.